How much profit has DOD Biotech PCL made this year?
DOD Biotech PCL has made 7.19 M THB this year.
In 2024, DOD Biotech PCL's profit amounted to 7.19 M THB, a -101.8% increase from the -398.33 M THB profit recorded in the previous year.
YEAR | NET INCOME (undefined THB) |
---|---|
2023 | 7.19 |
2022 | -398.33 |
2021 | 49.79 |
2020 | 141.25 |
2019 | 86.71 |
2018 | 305.26 |
2017 | 142.19 |
2016 | 138.78 |
2015 | 128.89 |
2014 | 47.27 |
The profit margins of DOD Biotech PCL represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of DOD Biotech PCL's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Evaluating DOD Biotech PCL's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
DOD Biotech PCL's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
When DOD Biotech PCL’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
DOD Biotech PCL has made 7.19 M THB this year.
The profit has increased by -101.8% compared to last year fallen
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
DOD Biotech PCL publishes its earnings in the form of quarterly or annual reports.
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
The profits of DOD Biotech PCL are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
You can learn more about the earnings of DOD Biotech PCL by reviewing the quarterly or annual reports or following the company presentations.
Over the past 12 months, DOD Biotech PCL paid a dividend of 0.05 THB . This corresponds to a dividend yield of about 2.02 %. For the coming 12 months, DOD Biotech PCL is expected to pay a dividend of 0 THB.
The current dividend yield of DOD Biotech PCL is 2.02 %.
DOD Biotech PCL pays a quarterly dividend. This is distributed in the months of .
DOD Biotech PCL paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0 THB are expected. This corresponds to a dividend yield of 0 %.
DOD Biotech PCL is assigned to the 'Non-cyclical consumption' sector.
To receive the latest dividend of DOD Biotech PCL from 5/20/2020 amounting to 0.05 THB, you needed to have the stock in your portfolio before the ex-date on 3/13/2020.
The last dividend was paid out on 5/20/2020.
In the year 2023, DOD Biotech PCL distributed 0 THB as dividends.
The dividends of DOD Biotech PCL are distributed in THB.
Our stock analysis for DOD Biotech PCL Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DOD Biotech PCL Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.